Evidence map›Paper›PMID 36249946›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2022

Sally Mehanna, Marwa Y Issa, Neven H Hassan, Ahmed M Hussien, Marwa A Ibrahim, Eman I Hassanen

Open access · hybridAbstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sally MehannaDepartment of Veterinary Hygiene and Management, Faculty of Veterinary Medicine, Cairo University, Egypt.
Marwa Y IssaDepartment of Pharmacognosy, Faculty of Pharmacy, Cairo University, Egypt.
Neven H HassanDepartment of Physiology, Faculty of Veterinary Medicine, Cairo University, Egypt.
Ahmed M HussienDepartment of Toxicology and Forensic Medicine, Faculty of Veterinary Medicine, Cairo University, Egypt.
Marwa A IbrahimDepartment of Biochemistry, Faculty of Veterinary Medicine, Cairo University, Egypt.
Eman I HassanenDepartment of Pathology, Faculty of Veterinary Medicine, Cairo University, Egypt.
Cairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neonicotinoid insecticide imidacloprid has been linked to significant reproductive damage in mammals. Origanum majorana essential oil (OME) is a natural herbal product used in the management of many diseases due to its strong antioxidant effects. The oil was hydrodistilled from O. Majorana and analyzed using GC/MS then its possible protective mechanisms against IMI-induced reprotoxicity in male rats were investigated. 28-adult male Wistar rats were divided into 4 groups as follows: group (1) control group, group (2) OME, group (3) IMI, and group (4) IMI + OME. The treatments were applied daily via oral gavage for 60 days. Remarkable abnormalities in both territorial aggressive and sexual behaviors were observed in IMI-treated rats with a significant elevation of serum FSH and LH as well as altered testicular redox status. Along with inhibition of the testicular expression of StAR and aromatase genes and serum total testosterone in addition to abnormal sperm count, viability, motility, and morphology. Histopathological examination showed severe degeneration and necrosis in both germ cells and Leydig cells with atrophy in most of the seminiferous tubules. Co-administration of OME with IMI notably improved all the above-mentioned studied parameters, and restored rats' spermatogenesis, sexual behavior, and favorably modulates the levels of both testosterone and gonadotropic hormones via its potent antioxidant effect. These findings support the use of OME as a fertility enhancer and suggest that it could be used to manage pesticide-induced male infertility.

Indexed as

CAT, CatalaseEF, Ejaculation frequencyEL, Ejaculation latencyFSH, Follicle stimulating hormoneGCA-S’cytes, Germ cell arrest at spermatocytesGSH, Reduced glutathioneHormonal disturbanceHPT, Hypothalamic-pituitary-testicular axisIF, Intromission frequencyIL, Intromission latencyImidaclopridIMI, ImidaclopridLH, Luteinizing hormoneLPO, Lipid peroxidationMDA, MalondialdehydeMF, Mount frequencyML, Mount latencyOME, Origanum majorana essential oilOriganumOxidative stressPEI, Post-ejaculatory intervalReproductive toxicityROS, Reactive oxygen speciesSC, Sertoli cellsS’gonia, SpermatogoniaSpermatogenesisStAR, Steroidogenic acute regulatory proteinTCA, Trichloroacetic acid

Identifiers

PMID36249946
PMCPMC9563047
OpenAlexW4283272815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.